Published on: 23017438. Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital filed on March 5, 2020.; Petitioner seeks a Declaratory Statement from the Board as to whether its intended pharmacist involvement in a penicillin skin testing program is appropriate under the auspices of the Drug Therapy Management Rule, 64B16-27.830, F.A.C., and the Prospective Drug Utilization Review Rule 64B16-27.810, F.A.C.
Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.
Published on: 22952448. The Board proposes the rule amendment to clarify language concerning the writer of the Prescriber Care Plan and to clarify language regarding the prescriber.
Published on: 22892502. The Board proposes the rule amendment to clarify language concerning the writer of the Prescriber Care Plan and to clarify language regarding the prescriber.
Published on: 21284824. Health First Inc. filed on December 18, 2018.; Petitioner seeks a Declaratory Statement from the Board to declare that Pettioner’s Penicillin Skin Testing (“PST”) program, as outlined in the petition, may be undertaken by the Petitioner’s hospital pharmacists under the auspices of the Drug Therapy Management Rule 64B16-27.830, F.A.C., and the Prospective Drug Utilization Review Rule 64B16-27.810, F.A.C.
Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.
Published on: 19185744. Eric Dietrich, Pharm.D.,; Petitioner seeks to clarify whether the clinical activities as described in the petition, including ordering and interpreting laboratory results, executing drug therapy orders which may include starting, stopping or adjusting medication doses, and providing clinical services in the outpatient setting, when performed under the direct supervision of a physician for an established patient in accordance with a Prescriber Care Plan signed by a physician that is in compliance with the rule, are within the scope of practice for a licensed Florida pharmacist.
Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.
Published on: 11480064. Gregory Milanich, RPh.; The petition requests the Board to issue a declaratory statement regarding Rule 64B16-27.830, Florida Administrative Code, as to whether pharmacists can enter into a proactive prescriber care plan with individual physicians for all their patients in long term care facility.